ELISA analysis was used to measure the serum levels of IGFBP-1 and IGF-1 in 142 NPC patients and 128 healthy controls and determine potential correlation with clinicopathological parameters. The gene discussed is IGFBP1; the disease is nasopharyngeal carcinoma.